Home

GENZ

Biotech Stocks on the Move: High Volume Traders; UVFT.OB, KBLB.OB, SGEN, GENZ

By Investorideas.com on Mon, 2010-09-27 13:35
(via www.investorideas.com)

InvestorIdeas.com, a leader in sector research for investors, reports on recent Volume Leading Biotech/ Pharma Stocks news and trading for September 27th on the OTCBB and NASDAQ Markets.

www.investorideas.com

Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp

Genzyme Rejects Bid from Sanofi Aventis

By pennystockexplosion on Mon, 2010-08-30 16:00
(via www.pennystockexplosion.com)

This morning people woke up to shares of Genzyme Corp. (NASDAQ:GENZ) trading sharply higher in pre-market trading. On Sunday, Genzyme received an $18.5 billion offer from Sanofi-Aventis (NYSE:SNY) which comes to $69 per share.

Will Biotech Heat Up the Penny Stock World?

By pennystockexplosion on Fri, 2010-07-30 12:05
(via www.pennystockexplosion.com)

History tells us that a high profile takeover of a company like GENZ usually spurs interest within the particular sector. This interest also can trickle down from the NYSE to the OTCBB as speculative money is getting freed up with the turn in the markets.

Biotechnology Stock Genzymes’ (GENZ) Hostile Takeover

By pennystockexplosion on Mon, 2010-07-26 11:34
(via www.pennystockexplosion.com)

Biotech company Genzyme (NASDAQ:GENZ) was the subject of takeover rumors. CNBC’s David Faber broke the story on a possible hostile takeover bid from Sanofi-Aventis (SNY-NYSE). Shares of Genzyme rallied sharply and are up roughly 17% at the time of this entry.

Genoptix, Inc. - A Vampire Stock

By wax on Mon, 2010-07-26 03:09
(via waxink.blogspot.com)

Indeed there are many vampires in the investing world whose single goal is to separate unwary individual investors from the their hard earned money, to take from them and from their families, their life blood.